Our firm's experience advising pharmaceutical, biotechnology and personalized medicine companies and investors has made us one of the leading law firms in these fields. We assist publicly traded companies to early-stage start-ups, and institutions from universities to large financial investors.
November 4, 2010 | Robinson Bradshaw Attorney Elected to NABL Board of Directors
October 25, 2010 | Four Robinson Bradshaw Attorneys Recognized as Best Lawyers Charlotte Lawyers of the Year
October 19, 2010 | Twelve Robinson Bradshaw & Hinson Attorneys Recognized by Benchmark Litigation
November 17, 2010 | Changing M&A Deal Terms in Changing Times
December 7, 2010 | Ethical Issues in Alzheimer's Disease
December 8, 2010 | Minding The Gap: A discussion of the financing and other issues encountered in the period between signing and closing M&A deals
October 15, 2010 | Cutting Costs While Preserving Mission
September 27, 2010 | Student-lawyers help legal community meet pro bono needs